| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ANAGRELIDE
| ANAGRELIDE | ANTINEOPLASTIC | ORAL | Tmax 1 HOUR F 70 PERCENT HT 1.5 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER | CYCLIC AMP PHOSPHODIESTERASE III | PHOSPHODIESTERASE 3 INHIBITOR CHEMBL2094125 PHOSPHODIESTERASE 3 Q13370 CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE B HOMO SAPIENS ENZYME PHOSPHODIESTERASE PDE_3 PDE_3B | ANSM (in French) | |||
